Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with a blood disorder called MPN (110 participants):
- You have been diagnosed with one of three specific blood conditions: Polycythemia Vera (PV), Essential Thrombocythemia (ET), or Primary Myelofibrosis (PMF)
- A specific type of DNA sample was collected from your white blood cells at the time of your diagnosis
- You have not received treatments such as chemotherapy or immunosuppressants that could affect DNA at the time of the sample
For people without MPN (10 participants):
- You do not have a blood cancer or blood disorder
- You were tested for a specific gene mutation (JAK2V617F) because of high platelet counts or high red blood cell levels for reasons other than MPN
- You have not received treatments such as chemotherapy or immunosuppressants that could affect DNA at the time of the sample
Who may not be able to join:
For people with MPN:
- You do not have PV, ET, or PMF
- The required DNA sample from your white blood cells was not collected at the time of your diagnosis
- You were receiving certain treatments (such as chemotherapy, drugs that affect DNA, or immunosuppressants) at the time your DNA sample was taken
- You have been followed up for less than 2 years since diagnosis
For people without MPN:
- You have any type of blood cancer or solid tumour (cancer in an organ)
- You were receiving certain treatments (such as chemotherapy, drugs that affect DNA, or immunosuppressants) at the time your DNA sample was taken
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Accelerated ageing of patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.